DLeader Secures ¥10 Million in Angel Investment to Pursue Its Vision for AI-Driven Drug Discovery

DLeader secured ¥10 million in angel investment from First Domino in June 2024. The funding will support the company’s first steps toward turning an ambitious idea for AI-driven drug discovery into a research and business initiative.

At this early stage, DLeader began with a bold vision: to expand the possibilities of drug discovery through AI. The investment provides support to develop that vision into a concrete technical and business direction.

By bringing together AI and drug discovery expertise, DLeader aims to create technologies that help researchers pursue new discoveries. With First Domino’s early backing, the company will advance its founding concept and establish the foundations for future development.